Terms: = Breast cancer AND GNA11, GNA-11, 2767, ENSG00000088256
18 results:
1. Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.
Xu B; Sun T; Shi Y; Cui J; Yin Y; Ouyang Q; Liu Q; Zhang Q; Chen Y; Wang S; Wang X; Tong Z; Zhong Y; Wang J; Yan M; Yan X; Wang C; Feng J; Wang X; Hu G; Cheng Y; Ge R; Zhu Z; Zhang W; Shao Z
Breast Cancer Res Treat; 2023 Feb; 197(3):489-501. PubMed ID: 36459284
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of ER, PR, and HER2 at the protein and mRNA levels in Asian patients with operable breast cancer.
Chen CJ; Chen TH; Lei J; Liang JA; Yang PS; Huang CS; Hsieh CM; Tseng LM; Liu LC; Cheng SH; Shih KH
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 35006257
[TBL] [Abstract] [Full Text] [Related]
3. Is there variation in private payor payments to cancer surgeons? A cross-sectional study in the USA.
Bongiovanni T; Kim SP; Kim A; Killelea B; Gross C
BMJ Open; 2020 Oct; 10(10):e035438. PubMed ID: 33020076
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.
Groen EJ; Hudecek J; Mulder L; van Seijen M; Almekinders MM; Alexov S; Kovács A; Ryska A; Varga Z; Andreu Navarro FJ; Bianchi S; Vreuls W; Balslev E; Boot MV; Kulka J; Chmielik E; Barbé E; de Rooij MJ; Vos W; Farkas A; Leeuwis-Fedorovich NE; Regitnig P; Westenend PJ; Kooreman LFS; Quinn C; Floris G; Cserni G; van Diest PJ; Lips EH; Schaapveld M; Wesseling J;
Breast Cancer Res Treat; 2020 Oct; 183(3):759-770. PubMed ID: 32734520
[TBL] [Abstract] [Full Text] [Related]
5. Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma.
Teh JLF; Purwin TJ; Han A; Chua V; Patel P; Baqai U; Liao C; Bechtel N; Sato T; Davies MA; Aguirre-Ghiso J; Aplin AE
Mol Cancer Ther; 2020 Aug; 19(8):1719-1726. PubMed ID: 32430489
[TBL] [Abstract] [Full Text] [Related]
6. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
[TBL] [Abstract] [Full Text] [Related]
7. Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark.
Vojdeman FJ; Madsen CM; Frederiksen K; Durup D; Olsen A; Hansen L; Heegaard AM; Lind B; Tjønneland A; Jørgensen HL; Schwarz P
Int J Cancer; 2019 Jul; 145(2):338-346. PubMed ID: 30613979
[TBL] [Abstract] [Full Text] [Related]
8. breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation.
de Boniface J; Frisell J; Bergkvist L; Andersson Y
Br J Surg; 2018 Nov; 105(12):1607-1614. PubMed ID: 29926900
[TBL] [Abstract] [Full Text] [Related]
9. Novel therapeutic strategies and targets in advanced uveal melanoma.
Chua V; Aplin AE
Curr Opin Oncol; 2018 Mar; 30(2):134-141. PubMed ID: 29206651
[TBL] [Abstract] [Full Text] [Related]
10. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract] [Full Text] [Related]
11. Advanced Stage at Presentation Remains a Major Factor Contributing to breast cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country.
Kong YC; Bhoo-Pathy N; Subramaniam S; Bhoo-Pathy N; Taib NA; Jamaris S; Kaur K; See MH; Ho GF; Yip CH
Int J Environ Res Public Health; 2017 Apr; 14(4):. PubMed ID: 28420149
[No Abstract] [Full Text] [Related]
12. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract] [Full Text] [Related]
13. Uveal melanoma: From diagnosis to treatment and the science in between.
Chattopadhyay C; Kim DW; Gombos DS; Oba J; Qin Y; Williams MD; Esmaeli B; Grimm EA; Wargo JA; Woodman SE; Patel SP
Cancer; 2016 Aug; 122(15):2299-312. PubMed ID: 26991400
[TBL] [Abstract] [Full Text] [Related]
14. Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic breast cancer: an Anatolian Society of Medical Oncology Study.
Uncu D; Bayoglu IV; Arslan UY; Kucukoner M; Artac M; Koca D; Oguz A; Demirci U; Arpaci E; Dogan M; Kucukzeybek Y; Turker I; Isikdogan A; Guler T; Zengin N
Asian Pac J Cancer Prev; 2015; 16(9):4127-31. PubMed ID: 25987098
[TBL] [Abstract] [Full Text] [Related]
15. Defining cisplatin incorporation properties in thermosensitive injectable biodegradable hydrogel for sustained delivery and enhanced cytotoxicity.
Abdel-Bar HM; Abdel-Reheem AY; Osman R; Awad GA; Mortada N
Int J Pharm; 2014 Dec; 477(1-2):623-30. PubMed ID: 25445973
[TBL] [Abstract] [Full Text] [Related]
16. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
[TBL] [Abstract] [Full Text] [Related]
17. Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
Roll JD; Rivenbark AG; Sandhu R; Parker JS; Jones WD; Carey LA; Livasy CA; Coleman WB
Exp Mol Pathol; 2013 Dec; 95(3):276-87. PubMed ID: 24045095
[TBL] [Abstract] [Full Text] [Related]
18. Reduced expression of gna11 and silencing of MCT1 in human breast cancers.
Asada K; Miyamoto K; Fukutomi T; Tsuda H; Yagi Y; Wakazono K; Oishi S; Fukui H; Sugimura T; Ushijima T
Oncology; 2003; 64(4):380-8. PubMed ID: 12759536
[TBL] [Abstract] [Full Text] [Related]
